Healthcare
Bearish Bets: 3 Stocks You Should Really Consider Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
These Small-Cap Biotech Stocks Have the Wind at Their Back
After getting a 'win' earlier this week on an acquisition, let's highlight a few similar names in my portfolio.
Why Are CRISPR Therapeutics Charts Saying 'Buy'?
Here's where traders could go long.
Is It Time to Get Back Into CVS Health? Here's a Trade Idea
The fundamentals are not in tip-top shape, and now investors have reduced guidance to deal with.
Bearish Bets: 3 Well-Known Stocks You Should Consider Shorting This Week
These recently downgraded names are displaying both quantitative and technical deterioration.
Shockwave Medical Could Shock With an Upside Breakout
The medical device maker had an attractive chart even before the takeover rumors.
Lilly Has a Hot Obesity Drug: Here's How to Trade the Stock
On top of all the other best-selling drugs in the firm's stable, Mounjaro has game-changer type potential.
Novavax Rallies and More Gains May Lie Ahead
Here's where aggressive traders could go long.
Zoetis Shares Are Barking Up the Right Tree
Shares of the animal healthcare company are poised to run further.
Vertex Pharmaceuticals Continues Its Impressive Rally: How to Play It
Buyers have been acting more aggressively than sellers.
With Jenny Craig Closing, Let's Weigh In with a Game Plan for Weight Watchers
The stock of parent company WW International has had a tremendous run so far this year, but its charts indicate it may trim down a bit near term.
CVS Slips After Earnings -- But Is This a Bad Thing?
There are several things to be encouraged about on the charts. Here's how I'd play the stock.
Is AbbVie a Buy on Weakness?
Here's what the charts and indicators reveal after earnings.
UnitedHealth Takes Shareholders on a Wild Roller Coaster Ride
Now may not be the time to enter the healthcare giant's stock based on the bigger picture painted by its charts.
These Biotech Names Could Be the Next Logical Buyout Targets
Nothing sparks the animal spirits in the biotech sector like a significant acquisition.
Teladoc Health Is Showing Improvement on Its Charts
The shares of the provider of virtual healthcare services could stage a modest comeback based on its technical signals.
Regeneron Set to Reach New Heights: $1,000 in Sight?
Here's how traders can play it.
Zimmer Biomet Looks Constructive and Ready to Climb
Here's how to play this medical device company.
A Sustainable Bull Market Is Lifting Off
The status of the market has changed as seven of 11 sectors turn positive -- but not all sectors have pointed upward, so let's look at the charts for each.
Not Sure Where the Market Is Headed? Keep It Defensive With This Play
Wrapping a covered call strategy around this defensive name adds downside protection while enhancing its yield.
Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'
Let's review the charts of PACB again.
Does Silk Road Medical Have a Smooth Path Forward?
After gaining a fundamental supporter, here's how aggressive traders could play the stock.
Medtronic Could Touch a New Low as It Bottoms
Let's see what the the charts and indicators look like.
Gilead Sciences Could Retreat Further From Here
Share prices peaked in December.
Boston Scientific's Wicked Rally Can Take the Stock 20% Higher
BSX has rallied the past nine months.
Why Weakness in Sarepta Therapeutics Is Likely to Continue
The trading days between the gaps look like an island surrounded by water.
When Will AbbVie's Long-Term Trend Reassert Itself?
Let's drill down on the charts.
3 High Dividend Healthcare Stocks for Passive Income
These recession-resilient names offer above-average dividend yields and decent growth prospects.
Here's How Innovation Can Drive Apple Higher
The tech giant's stock won a buy rating from Goldman Sachs, and its work on a medical innovation could be a game-changer.
As Covid Threat Weakens, This Biotech Is Still Worth a Shot
Here's a way to trade Vir Biotechnology.